Omega Gliadin IgG

You cut back on bread and pasta, felt better, and now you want to know whether your immune system is actually reacting to gluten or whether it was something else. This test looks for one type of antibody your body makes against gliadin, a protein found in wheat gluten.

It is an older, context-dependent marker rather than a definitive test. A raised level tells you your immune system has noticed gluten, but on its own it cannot diagnose a disease, which is why what you do next matters more than the number itself.

What This Antibody Actually Reflects

The thing being measured is IgG (immunoglobulin G), one of the main classes of antibody your immune cells produce after they encounter something from outside the body. Here, that something is gliadin, a component of the gluten in wheat. So the test reflects immune recognition of gluten, not damage to your gut, an allergy, or the severity of any condition.

Most laboratory gliadin antibody tests use a wheat protein mixture containing several gliadin types, including alpha, beta, gamma, and omega gliadins. In one research group's older work, the omega gliadin fraction produced the strongest and cleanest antibody signal, which is one reason it was singled out for testing. That finding is not universal, though: other older studies found no clear advantage for any single gliadin subfraction, so treat it as one group's result rather than settled consensus.

A useful anchor: these antibodies are common. Anti-gliadin antibodies show up in roughly 10% of the general population as a routine response to eating gluten. That alone tells you a positive result is not automatically a red flag.

Why It Is Not a Celiac Diagnosis

The older, native anti-gliadin IgG that this test belongs to has low diagnostic reliability for celiac disease. It produces frequent false positives and is meaningfully less accurate than the tests doctors now rely on. In head-to-head comparison, it catches fewer true cases than either the deamidated gliadin version or the standard tissue transglutaminase test.

Source: Rashtak et al., a study of 216 people comparing these tests before treatment. One caveat: the tissue transglutaminase IgA sensitivity in this single study (about 78 out of 100) is lower than the figure usually reported for that test, which is consistently above 95 out of 100 across larger reviews and guidelines. The table shows the relative ranking, not the best-case performance of the first-line test.

What this means for you: if the real question is whether you have celiac disease, this is not the test to lean on. Current pediatric guidelines recommend starting with tissue transglutaminase IgA (an antibody against an enzyme in your gut lining) plus a total IgA level, and they specifically advise against gliadin peptide antibodies for that first step.

This is where the marker can be misread. It is not a simple good-number, bad-number test. A positive result signals that your immune system has recognized gluten, and because that happens in about 1 in 10 healthy people, the antibody is best understood as an indicator of gluten exposure and immune reactivity, not proof that anything is wrong.

Gluten Sensitivity and Persistent Gut Symptoms

Where this antibody draws the most current interest is non-celiac gluten sensitivity, a pattern of symptoms after eating gluten in people who do not have celiac disease. There is no validated blood marker for that condition, but anti-gliadin IgG is one of the tools studied in this space.

In a study of 75 people with irritable bowel syndrome (a common cause of bloating, cramping, and altered bowel habits), those who carried anti-gliadin IgG reported less diarrhea after going gluten-free, and were more likely to see overall symptom improvement, than those without the antibody. The size of that benefit was hard to pin down precisely, but the direction was consistent.

For you, this is the most practical angle. If you have unexplained gut symptoms and standard celiac testing is clean, a positive result here is a reasonable prompt to discuss a supervised gluten-free trial with a clinician, rather than a diagnosis in itself.

A Possible Signal Beyond the Gut

Some human studies have reported higher anti-gliadin IgG in specific groups outside classic gut disease. In one study of 140 children, the anti-gliadin IgG response was significantly greater in autistic children who also had gastrointestinal symptoms than in those without them.

Links to neurological and psychiatric conditions are mixed and mostly low-level, and their meaning is uncertain. In healthy adults, having these antibodies by chance was not tied to any measurable brain or cognitive deficit. Treat findings in this area as interesting context, not established fact.

Not the Same as a Wheat Allergy

This is the single most common point of confusion, and it comes straight from the specimen. This test measures IgG. A true wheat allergy, including the exercise-triggered form that can cause anaphylaxis, is driven by a different antibody class called IgE (immunoglobulin E), which is what sets off immediate allergic reactions.

For wheat allergy, the well-validated blood marker is IgE against omega-5 gliadin, a different measurement entirely from the IgG this test reports. If your concern is hives, swelling, or a serious reaction after eating wheat, the IgE-based allergy testing is what you need, not this antibody.

Why One Reading Is Rarely Enough

This antibody responds to what you eat, which makes a single snapshot less useful than a trajectory. When gluten is removed from the diet, gluten-related antibodies typically fall, with a decline that usually begins within months. Full normalization, though, takes longer, with celiac-related antibodies commonly returning to normal over roughly 12 to 36 months. That responsiveness is exactly what makes tracking valuable.

A sensible approach: get a baseline while you are still eating gluten normally, retest 3 to 6 months after any deliberate dietary change, then at least annually if you are watching this. A clear downward trend after cutting gluten is more informative than any one value, and it doubles as a way to confirm you are actually sticking to the diet.

One caveat worth keeping in mind: the fall in antibodies on a gluten-free diet has been documented for anti-gliadin antibodies broadly, rather than for the omega gliadin fraction studied in isolation. The general pattern is well established, but the exact pace for your specific reading can vary.

When a Single Reading Can Fool You

• Already eating gluten-free: if you have cut out gluten before testing, your antibody level can fall to normal even when your immune system would react to gluten. A normal result in that situation does not rule anything out.
• Common in healthy people: because these antibodies appear in roughly 10% of the general population, an isolated positive with no symptoms often means nothing at all. The test's tendency toward false positives is its biggest weakness.
• Assay-to-assay differences: this is an older, non-standardized marker, and different laboratories can report different numbers for the same sample. Compare trends within the same lab rather than across labs.

What to Do With an Unexpected Result

A raised level is a starting point, not an endpoint. The most useful next move is to order tissue transglutaminase IgA together with a total IgA level, since that combination is the guideline-backed first step for celiac disease and total IgA reveals whether an IgA deficiency is throwing off the picture.

From there, patterns guide action. A raised gliadin IgG alongside a raised tissue transglutaminase IgA warrants a serious celiac workup with a gastroenterologist, ideally before you remove gluten, because going gluten-free early can erase the findings needed to confirm a diagnosis. A raised gliadin IgG with normal tissue transglutaminase but ongoing gut symptoms points more toward a supervised gluten-free trial and a non-celiac gluten sensitivity evaluation. If your symptoms are immediate allergic reactions, an allergist and IgE-based testing are the right path instead.